Mayo Clinic Ovarian Cancer Study

Contact: Ellen L. Goode, Ph.D.

Number of Enrolled Cancer Patients/Survivors: ~900
Years of Diagnoses of Enrolled Cancer Patients/Survivors: 2000+
Approximate Years of Follow-up: Up to 11 years
Cancer Sites Represented: Ovary
Biological Specimens Collected: Blood/Blood Fraction
Buccal Cells
Normal Tissue
Germline DNA
Formalin Fixed Tumor Tissue
Fresh Frozen Tumor Tissue
Treatment Outcome Measures: Physician/Medical Record Reported
  • Symptom Assessment
  • Acute Medical Event
  • Late Medical Event
  • Cancer Recurrence
  • Death
Patient-Reported
  • Cancer Recurrence
  • Death
Co-morbidities at Study Entry: None
Lifestyle Factors: Smoking
Alcohol Use
Diet
Physical Activity
Body Mass Index
Weight Loss/Control
Treatment Data: Surgery
Radiation
Chemotherapy
Hormonal Therapy
Treatment Data Assessed By: Electronic Record
Chart Abstraction
Is the study open to collaboration? Yes

[Return to Top]

Last Updated: 25 Oct 2012

Division of Cancer Control and Population Sciences National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov